Development and validation of an integrated machine learning model for recurrence-free survival prediction in clear cell renal cell carcinoma.
Source check: Source checked. Not independent scientific confirmation.
Finding: The full text confirms a five-hospital retrospective cohort of 1,284 ccRCC patients with training, internal-validation and independent external-test sets; 3D-ViT and radiomics signatures contributed to RFS prediction, with reported external performance.
Technology: The full text confirms a five-hospital retrospective cohort of 1,284 ccRCC patients with training, internal-validation and independent external-test sets; 3D-ViT and radiomics signatures contributed to RFS prediction, with reported external performance.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The full text confirms a five-hospital retrospective cohort of 1,284 ccRCC patients with training, internal-validation and independent external-test sets; 3D-ViT and radiomics signatures contributed to RFS prediction, with reported external performance.
- Test and result
- The integrated clinical/radiomics/deep-learning model combined CT features with clinical data; external-test C-index was 0.820 and 3-, 5- and 7-year AUCs were reported.
- Limitation / still unknown
- The multicenter retrospective external test supports prognostic discrimination; it does not establish prospective clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13449481/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.